Sell $50k worth and take up the SPP at $1.35 - $1800 gain is kinda nice for a festive Christmas dinner? Some bottles of champagne for the family?
Printable View
Fair comment. I bought enough to keep my holding from being diluted but that was it. SP may have gotten ahead of itself, as it does sometimes, so no big deal if there's a pull back. In the near term it sounds as though PEB is flagging that things might have stalled a bit due to Covid, but beyond that I fall into the camp that thinks PEB has huge potential if things go its way. Who dares wins.
Or I could buy $50k worth at $1.15? balance!
And buy an even bigger xmas prezzie
Cap raise playing with SP knocking it back a bit from where it was heading 1.59+ is an unfortunate side effect of raising so much capital as there will always be those quick profit takers out for a short term buck. Holders are the ones who genuinely can see the trajectory and path PEB is currently on. This hasn't changed with some play in the SP. The positioning of the company and what they will now be able to use this large amount of capital for will excel PEB to the next level. SP at only a buck 50 will be seen as cheap as chips soon enough when its growth really kicks off. The world will soon learn to live with Covid, medical advancements in other areas will regain focus and traction. More positive news will follow with PEB entering and becoming established in US and other new markets. The success is yet to really be seen and realised. Some traders will play their swings, selling down as they have been to try and rebuy as close to 1.35 as possible. Some of those who buy at 1.35-1.4 will only be looking for a quick 10% so might see some resistance around 1.45-1.5 for a while until these small profit gainers clear out the way. Then once that volume has sold out SP will push steadily higher with more and more good news and traction to follow. It's still early days. Seems to be a common occurrence with large cap raises. The extra $20M thrown in didn't help seeing the slide from 1.59 to where it is now. But again depends on if short sighted 8-10% profits are desired or much larger profits. Patience will play out a good fortune to those with a steady hand. This will likely be NZ's next success story company. It has taken a while to get to where they are now, but the train has left the station. When ASX kicks in within the next 6 months once the dust has settled with Cap Raise, and PEB hits headlines more in Australia, SP will be a fast train. So holders don't be disappointed if see SP dip as it has recently, and maybe even stagnate there for a while which is only logical. Once flippers clear out SP will rally strong soon enough to follow. All aboard :)
Spot on Maxtrade. The PEB ship will come in - not this year - but the treasure is on board for those willing to wait. A 10% gain on a quick trade (less tax of course) will look pathetic compared with what is yet to come.
The current wobbling of the SP doesn't look great but we've seen this kind of action many times before. Those trying to push the price down to score a lower entry into the SPP have left their run a bit late and it will be all over tomorrow. There's no sweat on my brow from the current SP action.
Patience Grasshopper!
The newsletter had a pinch of downbeat tone to it for the numbers this FY. Atleast we will be able to see the publication on Singapore trials in a few months.
Last day for getting your SPP applications in if you are interested in getting more shares.
Sp action this morning suggests ‘SPP’ application regret as applicants (having applied) bail out of equivalent existing stock to lock in whatever profit is left in the SPP price of $1.35?
Must admit I thought of doing the same on Monday but what the heck, hardly worth the effort now.
$1.35, there it is!
Slightly annoyed with Sharesies as they communicated they needed applications in by 11am monday rather than today. They corrected this about an hour after I made my application and I'd be hesitating now tbh...
Yeah very poor management of the CR. You would think those in management would have a little better understanding of how markets work. They should have left the demand there which would have netted the same results with inflowing demand while pushing the SP and value of the company up simultaneously. The extra $20M released should have been left to the retail offer. Now there will be a drag on the SP to get rid of those extra traders that bought in at $1.35 just looking to make money on the post CR bounce and not actually investing in the company itself and it's future. Anyway it's probably just slowed SP progression and momentum down until the mud gets kicked off it's boots. I wouldn't be surprised if we see 1.30 tested as quick profit takers realise they may not be getting their quick profits that soon after all. Which obviously won't be the best for the instos and retail investors who bought in at 1.35, as the 5 day average won't be any lower even if it were to drop to 1.30 today. I guess those who held off on the offer were waiting to see if would drop below 1.35. If does touch down to 1.30 I would suspect to see a surge of buyers enter. Knowing will likely quickly bounce back uo 1.35 following a short dip. Hover for a while then slowly trudge it's way through the mud north into clearer waters again.
Yep they screwed up in terms of looking after shareholders and SP by throwing an extra 20 million on the table. But like you say good for the company to have those funds to put to work. But only really applicable to longer term holders rather than traders. The battle of the short-term traders versus true believers in PEB's medical advancements and where they are heading. I wish investing was still actually investing in a company. It's almost like traders need to have their own division in a company separate from actual investors in the company. I know that is not realistically achievable but wouldn't that be great! Stocks in company shouldn't be seen as a quick buck or gambling, it should be investing in a company and it's future.
I don't look at it that way myself.
Traders can add depth & liquidity o a stock and there have been many a time when I have bought cheap and plenty from traders.
The answer for PEB & similar companies to avoid volatility is to access the private equity market but that's easier said than done for high risk biomedical & biotech companies.
It was written...
I don't see the raise as a screw up at all... The board acted in the best interests of the Company. Revising the placement price upward was made possible by eager investors. You'll likely find about the same number of shares were issued but the difference in strike price netted more capital... If punters coughed up $$ to early that's an issue for the punter, not the company. It's one of the few instances where shareholders interests and the companies interests don't align. The whole point of having a listed company is to access capital. Job well done
I'm expecting more softening to come. That's a hunch, no agenda. I've a small holding to keep my interest...
Yeah not a lot of support on the buy side of ASX currently. Surely won't see a fall back to 1.2 AUD though?? If so would likely find a bottom there and be very brief followed by a rally to follow suit then?
Down 7.5% on ASX currently. Who knows, maybe it will test 1.2 AUD by tomorrow?? Will be prepared for a rally if there is a bit of a brief sell off dipping to this level.